Experienced Leadership
The Cyrene Health Therapeutics leadership team is comprised of medical, clinical, and pharmacology experts with extensive experience conducting research and development in CNS and chronic pain. With a proven track record in completing numerous clinical trials for controlled substances and psychedelic-based therapies, our team brings specialized knowledge and a commitment to advancing innovative treatments through rigorous scientific and clinical expertise.
Leadership Team
Renzo G. DiCarlo
P. Eng., MBA, MiM Economics
Renzo G. DiCarlo
P. Eng., MBA, MiM Economics
Renzo G. DiCarlo, P. Eng., MBA, MiM Economics, brings visionary leadership to the biopharmaceutical industry, with over 25 years of expertise driving innovation and transformation in rare disease therapies. His career reflects a steadfast commitment to advancing treatment solutions across global markets.
- A Proven Leader in Rare Disease Innovation
Renzo’s focus on rare disease R&D development has shaped his legacy as an industry trailblazer. He has spearheaded critical product development initiatives, combining scientific advancement with strategic execution to deliver impactful outcomes for patients worldwide. - Executive Excellence Across the Globe
With a dynamic track record as Chief Executive Officer and Board Member at Biopharma Services, Renzo expanded clinical operations into the United States and strengthened bioanalytical lab capacities to meet growing demand. His leadership extends across oncology, nuclear medicine, and rare cancer research, building robust platforms for therapeutic breakthroughs. - A Global Perspective on Life Sciences
Renzo’s career spans senior executive roles in the life sciences sector across North America, Europe, Asia, and Africa. He has successfully collaborated with diverse teams to develop and deliver first-in-world NDA-approved drugs and medical devices, navigating complex regulatory landscapes and fostering innovation in multilingual, multicultural environments.
Amal Abuzgaya
M.Sc.
Amal Abuzgaya
M.Sc.
Driving Innovation in Healthcare and Life Sciences
Amal Abuzgaya is a dynamic leader with over 12 years of experience advancing strategic initiatives in the healthcare and life sciences industry. Her career is distinguished by her ability to steer high-growth organizations toward success through forward-thinking solutions.
- Specialized Expertise in Biopharmaceutical Communications
With a focus on the biopharmaceutical sector, Amal excels in crafting and executing innovative digital marketing and communication campaigns. Her achievements have earned recognition through multiple industry awards, celebrating her work across neurology, dermatology, rare diseases, and rheumatology. - Collaborative Leadership and Mentorship
Amal is known for fostering cross-functional collaboration, building strong professional relationships, and mentoring teams to achieve business objectives. Her human-centred leadership approach empowers organizations to navigate complex challenges and deliver meaningful results. - Academic Insight and Research Excellence
Holding a Master of Science in Medicine, Science & Society from King’s College, University of London, Amal’s research at King’s College Hospital London explored trauma in transcultural psychiatry, deepening her understanding of global healthcare challenges. - A Passion for Transformative Therapeutics
Amal’s professional journey and academic foundation fuel her passion for supporting Cyrene Health Therapeutics’ mission to deliver innovative, science-driven solutions for chronic pain and neuro-inflammatory diseases.
Fathi Abuzgaya
M.D., F.R.C.S.(C).
Dr. Fathi Abuzgaya
- Decades of Expertise in Orthopaedic Care
Dr. Fathi Abuzgaya brings over 35 years of experience as a distinguished orthopaedic surgeon, with a deep commitment to advancing surgical excellence and patient outcomes. - A Proven Track Record in Clinical Research
For more than 20 years, Dr. Abuzgaya has led groundbreaking clinical research as a Principal Investigator, collaborating with leading pharmaceutical companies and specialized biotech firms. His research spans hip and knee replacements, CNS disorders, and chronic pain, driving innovation in treatment solutions. - Leadership Across Healthcare Institutions
Dr. Abuzgaya has held pivotal roles at Lakeridge Health Ajax Pickering Hospital, serving as Surgical Program Director, Chief of Medical Staff, and Chief of Orthopaedic Surgery. His leadership extends to his affiliations as a courtesy staff member at the University Health Network and as an Adjunct Professor in the Department of Orthopaedics at the University of Toronto. - Focused on Advancing Care and Education
Dedicated to improving orthopaedic care, Dr. Abuzgaya’s clinical interests include arthritis management, arthroscopic surgery, and reconstructive procedures. His research efforts focus on leveraging evidence-based practices, leading FDA and Health Canada-approved multi-centre trials, enhancing education for primary care physicians and orthopaedic surgeons, and providing independent medical evaluations.
Ahmed Elharram
PhD
Ahmed Elharram
PhD
- An Accomplished Leader in Pharmaceutical Innovation
Ahmed Elharram is a highly accomplished leader in the pharmaceutical industry, bringing extensive expertise in the Respiratory Therapeutic Area. His career spans a range of roles within Medical Affairs, including MSL, MSL Manager, Medical Advisor, and Medical Lead, where he has consistently fostered innovation, growth, and a strategic, competitive mindset. - Driving Collaboration and Education Across Canada
Ahmed has built strong relationships with patient and physician organizations, working collaboratively to advance the understanding of diseases. He has led multiple large-scale Medical Education initiatives nationwide, reinforcing his commitment to knowledge sharing and improved healthcare outcomes. - Expertise in Neuroscience and Scientific Communication
With over seven years of neuroscience research training and teaching, Ahmed holds advanced knowledge in pharmacology, inflammation, neuroscience, and Alzheimer’s Disease. His outstanding scientific communication and presentation skills have earned him multiple awards and recognition at scientific meetings, further establishing his reputation as a respected voice in the field.
John Oldenhof
PhD
John Oldenhof
PhD
- Advancing Therapeutics Through Clinical Pharmacology and Rare Disease Advocacy
Dr. John Oldenhof is a recognized leader in clinical pharmacology with over 25 years of experience in early-phase drug development, regulatory science, and neuropharmacology. His extensive research background includes addiction science, pain therapeutics, and multiple clinical studies involving psychedelic compounds. His career spans hundreds of clinical studies, including first-in-human, drug-drug interaction, and thorough QT studies supporting global regulatory submissions. - A Trusted Expert in Clinical Development Strategy
As a member of the leadership team at Cyrene Health Therapeutics, Dr. Oldenhof brings strategic insight and deep clinical expertise to the development of novel therapeutics. He has served as Chief Scientific Officer and has led scientific and regulatory teams across a range of global clinical programs, spanning Phase I through Phase III. His experience includes work in both CRO and biotech environments, where he guided the design and execution of early- and late-stage studies, contributing to successful regulatory submissions and product development milestones. - Committed to Education and Scientific Excellence
John holds a PhD in Molecular Neuropharmacology and serves as an adjunct lecturer at the University of Toronto’s Department of Pharmacology & Toxicology. In this role, he shares his deep knowledge of CNS pharmacology and clinical trial methodology with the next generation of scientists. - A Personal Mission in Psychedelic and Pain Therapeutics
Dr. Oldenhof brings a personal and scientific commitment to advancing evidence-based psychedelic therapies for chronic pain. His work reflects decades of experience in neuropharmacology and pain research, including clinical studies involving psilocybin and other novel psychedlic therapeutics. He is passionate about translating cutting-edge science into meaningful clinical advancements for individuals living with persistent pain conditions. - Championing Science-Driven Innovation at Cyrene
John’s professional expertise and personal commitment align with Cyrene Health Therapeutics’ mission to develop transformative treatments for chronic pain and neuro-inflammatory diseases. His experience bridges the scientific, clinical, and patient communities—driving forward impactful change in therapeutic discovery and care.
